XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 25,000 $ 25,000
Prepaid expenses 498,306
Total current assets 523,306 25,000
Deferred offering costs associated with proposed initial public offering 180,805
Other assets 184,794
Cash equivalents held in Trust Account 300,015,536
Total Assets 300,723,636 205,805
Current Liabilities:    
Accrued expenses 479,418 76,294
Payables to related party 105,805
Sponsor loan - promissory notes 910,962
Franchise tax payable 145,455
Total Current Liabilities 1,535,835 182,099
Warrant liability 6,140,000
Forward purchase securities liability 2,645,660
Total Liabilities 10,321,495 182,099
Commitments and Contingencies
Class A common stock subject to possible redemption, 30,000,000 and 0 shares at redemption value of $10.00 per share as of September 30, 2021 and December 31, 2020, respectively 300,000,000
Stockholders’ Equity (Deficit):    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of both September 30, 2021 and December 31, 2020
Class A common stock, $0.0001 par value; 160,000,000 shares authorized; 700,000 issued and outstanding (excluding 30,000,000 shares subject to possible redemption) as of September 30, 2021 and no shares issued and outstanding as of December 31, 2020 70
Class B common stock, $0.0001 par value; 40,000,000 shares authorized; 7,500,000 and 8,625,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 750 863
Additional paid-in capital 24,137
Accumulated deficit (9,598,679) (1,294)
Total Stockholders’ Equity (Deficit) (9,597,859) 23,706
Total Liabilities and Stockholders’ Equity (Deficit) $ 300,723,636 $ 205,805